BioCurate’s Mission

BioCurate’s mission is to grow the Victorian and Australian biotech sector by translating medical research outputs into high quality preclinical candidates for the bio-pharmaceutical industry. Our goal is to be a recognised global leader in the translation of basic medical research into human therapeutics.

A bold, collaborative venture, BioCurate was jointly formed in 2016 by Monash University and the University of Melbourne, with support from the Victorian State Government. Operating independently, the Company is dedicated to growing the Victorian and Australian biotech sector by identifying promising biomedical research discoveries and managing their translation into high quality pre-clinical candidates. The team works specifically in the under-resourced, yet critical, early phases of therapeutic development to drive early decisions, address key challenges, and to overcome common barriers to success.

BioCurate’s team of experts bring hands-on industry experience and a global track-record in the successful development and commercialisation of a range of therapeutic modalities spanning a diverse array of diseases. Working in concert with other specialists and a global network, BioCurate provides a robust bridge between academia and industry within the biotechnology sector.

The team employs rigorous biopharma business practices to increase the number, quality and rate of new therapeutic discoveries and to translate them into medically sound projects that are attractive for investment through a commercial pathway, such as the biopharmaceutical industry or venture capital companies, or via a public route, such as philanthropic funding agencies.

BioCurate is committed to supporting and mentoring talented academic researchers to help build their capability, translate their projects, and to ultimately fulfill the vision of delivering clinical impact to patients through the development of new therapies.

BioCurate brings benefit to our community by helping to advance Australian research and innovation globally.

Return to About
Share